Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF654 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CNPY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM63B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM230 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CGGBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTFR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
S100A13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP89 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARMC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB40C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PANX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP90 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YWHAH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VDAC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRPRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on